trial · primary record
68Ga-NOTA-ABSCINT-HER2 PET/CT
Metastatic Breast Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2026-12-31 |
| Primary endpoint | positive, negative, and overall diagnostic agreement between 68Ga-ABS011 PET/CT and the standard of care IHC (and ISH) HER2 status test. |
| Registry ID | NCT06369831 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:51.348Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06369831
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.